Rating History for Terns Pharmaceuticals (TERN) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/9/2026 | Andrew Berens | New Coverage | Outperform (N/A) |
58.00 (N/A) |
37.77 (42.82) |
13.37% | Details |
